The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2025 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2025 Earnings Call Transcript November 13, 2025The Oncology Institute, Inc. beats earnings expectations.
Oncology Institute Inc. (TOI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 3,360,052 | $11,726,581 | 0.18% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 2,518,337 | $8,788,996 | 0.01% | |
| 3. | Wexford Capital Charles Davidson | 1,571,069 | $5,483,030 | +41% | 0.79% |
| 4. | Millennium Management Israel Englander | 951,001 | $3,318,993 | +135% | 0% |
| 5. | Renaissance Technologies Jim Simons | 750,500 | $2,619,245 | +65% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.04 | 45,280 | $47,168.18 | 712,033 | 2025-03-26 | Filing | |
| $1.04 | 22,640 | $23,584.09 | 724,363 | 2025-03-26 | Filing | |
| $1.04 | 9,056 | $9,433.64 | 79,049 | 2025-03-26 | Filing | |
| $1.04 | 90,562 | $94,338.44 | 224,971 | 2025-03-26 | Filing | |
| $1.04 | 36,224 | $37,734.54 | 203,409 | 2025-03-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.56 | 247 | $879.32 | 235,122 | 2026-01-02 | Filing | |
| $3.77 | 13,333 | $50,290.74 | 683,721 | 2025-12-15 | Filing | |
| $4.00 | 46,630 | $186,520.00 | 174,971 | 2025-11-18 | Filing | |
| $4.00 | 1,210 | $4,840.00 | 221,601 | 2025-11-18 | Filing | |
| $4.00 | 2,160 | $8,640.00 | 222,811 | 2025-11-18 | Filing |
Institutional Investors' Holdings
News See All
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2025 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2025 Earnings Call Transcript August 13, 2025The Oncology Institute, Inc. misses on earnings expectations.
10 Best Performing Penny Stocks So Far in 2025
By midday Wednesday, July 23, 2025, the Russell 2000 was up 1.57% for the week. This compares to a 0.9% gain for the S&P 500.
The Oncology Institute Becomes Exclusive Oncology Provider for 80,000+ SilverSummit Healthplan Medicaid Members
The Oncology Institute Inc. (NASDAQ:TOI) is one of the best-performing NASDAQ stocks according to analysts. On June 30, the Oncology Institute announced a partnership with SilverSummit Healthplan.
12 Best Performing NASDAQ Stocks According to Analysts
On July 3, Dan Ives, the Global Head of Tech Research at Wedbush, appeared on CNBC to suggest that AI will fuel a multi-year tech rally. Ives stated that he believes they are only at the beginning of...
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2025 Earnings Call Transcript
Operator: Good afternoon and welcome to The Oncology Institute's First Quarter 2025 Earnings Conference Call. Today's call is being recorded and we have allocated 1 hour for prepared remarks and Q&A.
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2024 Earnings Call Transcript
Mark Hueppelsheuser: Good afternoon, and welcome to The Oncology Institute, Inc.'s Fourth Quarter and Full Year 2024 Earnings Conference Call.
Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025
The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These stocks could get even hotter due to AI.
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to The Oncology Institute's Third Quarter 2024 Earnings Conference Call.
Hedge Fund Resource Center Billionaire Hedge Funds
